Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Moolec ScienceMLEC +0.21%42 EV-to-OCF is 13.06 as of Jul. 26, 2026, which is 25% below its 10-year median of 17.32. GuruFocus rates MLEC with a GF Score™ of 42/100 and a GF Value™ of $84.84 (Possible Value Trap). The stock has 9 warning signs investors should review. Among 1,409 Biotechnology companies, Moolec Science ranks worse than 85.17% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Moolec Science's Enterprise Value is $76.6 Mil.
Moolec Science's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was $5.9 Mil. Therefore, Moolec Science's EV-to-OCF for today is 13.06.
The historical rank and industry rank for Moolec Science's EV-to-OCF or its related term are showing as below:
MLEC'
s EV-to-OCF Range Over the Past 10 Years
Min: -4.1 Med: 17.32 Max: 71.52
Current: 13.06
During the past 5 years, the highest EV-to-OCF of Moolec Science was 71.52. The lowest was -4.10. And the median was 17.32.
MLEC's EV-to-OCF is ranked worse than 85.17% of 1409
companies
in the Biotechnology industry
Industry Median: -3.29
vs MLEC: 13.06
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Moolec Science's PE Ratio (TTM) for today is calculated as:
Moolec Science's share price for today is $7.195.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Moolec Science's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $-80.918.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Moolec Science EV-to-OCF Related Terms
Moolec Science EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Moolec Science's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Moolec Science's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Moolec Science EV-to-OCF vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Moolec Science's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Moolec Science's EV-to-OCF falls into.
Moolec Science's current Enterprise Value is $76.6 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Moolec Science's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was $5.9 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Moolec Science (MLEC) has a EV-to-OCF of 13.06 as of Jul. 26, 2026. This is 25% below median its historical median of 17.32. According to the industry distribution chart, Moolec Science ranks #1200 out of 1409 companies in the Biotechnology industry, placing it in the top 85.2%.
Is Moolec Science's EV-to-OCF too high?
Moolec Science's current EV-to-OCF of 13.06 is 25% below median its 10-year median of 17.32. Based on the distribution chart, Moolec Science ranks #1200 out of 1409 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Moolec Science has a GF Score™ of 42/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Moolec Science's EV-to-OCF compare to GNPX and ADIL?
According to the Biotechnology industry distribution chart, Moolec Science ranks #1200 out of 1409 companies for EV-to-OCF. This places Moolec Science in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Biotechnology company?
A good EV-to-OCF depends on the Biotechnology industry context. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. Moolec Science's current EV-to-OCF is 13.06, which is 25% below median its own 10-year median of 17.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Moolec Science stock overvalued right now?
Based on GuruFocus' analysis, Moolec Science (MLEC) is currently considered Possible Value Trap. The stock's GF Value™ is $84.84, compared to a current price of $7.20 — trading 91.5% below its estimated fair value. The current EV-to-OCF is 13.06, which is 25% below median its 10-year median of 17.32. Moolec Science's overall GF Score™ is 42/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Moolec Science (MLEC), the current EV-to-OCF is 13.06 as of Jul. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Moolec Science (MLEC) Overvalued in 2026?
Based on GuruFocus' analysis, Moolec Science stock appears to be undervalued.
The current stock price of $7.20 is trading 91.5% below its estimated GF Value™ of $84.84.
GuruFocus considers Moolec Science to be Possible Value Trap.
Key valuation signals for MLEC:
EV-to-OCF: 13.06 (25% below median its 10-year median of 17.32)
GF Value™: $84.84 vs. price of $7.20 (91.5% below fair value)
No single metric tells the full story. See the MLEC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline, such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's maximum revenues from operations in Argentina.
42GF Score
Get the complete analysis for MLEC
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MLEC has been successfully added to your 
